Detalhe da pesquisa
1.
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Nat Genet
; 55(3): 437-450, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849657
2.
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
medRxiv
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986741
3.
Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 13(22)2021 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830797